View a message below from Dr Marc Rothenberg of Cincinnati Children’s Hospital
Click Any of the Links Below to Read Details on Each Clinical Trial
2012 – Meritage commences OBS Phase 2 clinical trial for eosinophilic esophagitis
2012 – Cincinnati – Researchers Identify New Regulator in Allergic Diseases
2012 – Cincinnati – Genetic Marker for EE Identified
2011 Research Letter – Feinberg School of Medicine
Research Letter From Dr. Rothenberg 9-24-09
Eosinophilic Esophagitis (EE) Twins Needed!
Contact Alexandria Greenler, BS via email at alexandria.greenler@cchmc.org
Intravenous QAX576 Treatment for Eosinophilic Esophagitis
A New Discovery CURED Helped Fund – One Step Closer to a CURE
A Study of Flovent in Patients With Eosinophilic Esophagitis
Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis
Eosinophilic Esophagitis: Influence of Dilation on Dysphagia and Inflammation
Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis
Trial of Montelukast in Eosinophilic Esophagitis
Topical Steroid Treatment for Eosinophilic Esophagitis
The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis
Data Bank for Eosinophilic Disorders
Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis
Omalizumab to Treat Eosinophilic Gastroenteritis
Intravenous QAX576 Treatment for Eosinophilic Esophagitis
To read more about Clinical Trials, Click Here